As technology continues to grow at a rapid rate, companies need liberal arts majors who understand that, when it comes to AI, the inputs matter, and how you apply the technology has a critical impact on people.
Join the Technology & Digital Studies Program and Beyond the Dome as we invite industry experts to discuss how they're leveraging AI in their business and what students need to know to have successful careers in these industries.
October 15: Kevin O'Brien
Kevin O'Brien's Biography
Kevin O'Brien is an investor and board member at Lirio, a behavior change artificial intelligence
business focused on driving improved outcomes through AI-driven hyper-personalized wellness
and chronic condition management interventions; EmOpti, a founder-led telehealth business
focused on workflow improvements in health systems; and Memorial MRI, a Texas-based
freestanding imaging center and interventional pain business. He is also a board member of the
Special Operations Fund, a 501(c)(3) dedicated to the families of JSOC’s special mission units,
and an advisor to the U.S. Diplomatic Studies Foundation, a 501(c)(3) focused on supporting
and enhancing the educational and training needs of U.S. government departments and
organizations through innovative programs.
business focused on driving improved outcomes through AI-driven hyper-personalized wellness
and chronic condition management interventions; EmOpti, a founder-led telehealth business
focused on workflow improvements in health systems; and Memorial MRI, a Texas-based
freestanding imaging center and interventional pain business. He is also a board member of the
Special Operations Fund, a 501(c)(3) dedicated to the families of JSOC’s special mission units,
and an advisor to the U.S. Diplomatic Studies Foundation, a 501(c)(3) focused on supporting
and enhancing the educational and training needs of U.S. government departments and
organizations through innovative programs.
In 2021 he retired from CCMP Capital Advisors, LP, a New York-based private equity firm where,
over the previous 21 years, he was a Managing Director leading the healthcare practice and a
member of its Investment Committee. Mr. O'Brien was deeply involved in, and served on the
boards of CCMP investments including Eating Recovery Centers (behavioral treatment for mood
& anxiety, eating and related disorders), CareMore Medical Enterprises (Medicare Advantage
health plan), LHP Hospital Group (short-term acute care hospital company focused on JVs with
larger health systems), Medpace (contract research organization focused on human drug trials
primarily for biotech companies), National Surgical Care (ambulatory surgery centers),
Infogroup (marketing data services), and La Petite Academy (early childhood education).
Prior to joining JP Morgan Partners in 2000, CCMP’s predecessor firm, Mr. O'Brien worked in
investment banking in the high yield capital markets and banking groups at Chase Securities and
Chemical Securities. Prior to that, he was a Commissioned Officer in the U.S. Navy where he
served as a Surface Warfare Officer from 1988 to 1992.
Mr. O'Brien holds a B.A. from the University of Notre Dame and an M.B.A. from the Wharton
School of the University of Pennsylvania.